Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MTCO2P31 (Mitochondrially encoded cytochrome c oxidase II pseudogene 31) is a human processed pseudogene located on chromosome 6q25.2. It is derived from the mitochondrial protein-coding gene MT-CO2 but does not produce a functional protein or RNA. As a pseudogene, MTCO2P31 is not a therapeutic target, receptor, enzyme, or transporter, and is not associated with disease or pharmacology. Its presence is primarily of interest for evolutionary genomics, comparative studies, or copy-number variation analyses but not in clinical therapeutics.
no drug mechanism because the pseudogene does not encode a target protein
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mitochondrially encoded cytochrome c oxidase II pseudogene 31 (MTCO2P31).